From today's UK papers

November 30, 2000

FINANCIAL TIMES

Colin Lucas, vice-chancellor of the University of Oxford, writes that Oxford has made decision-making clearer and more efficient, has developed academic partnerships and is a pioneer in the commercialisation of intellectual property.

Cornell University in the United States has announced a breakthrough in nanotechnology - the development of tiny biomolecular motors with functioning propellers.

THE INDEPENDENT

Andrew Oswald, professor of economics at Warwick University, writes to the 150,000 students who demonstrated in London against tuition fees and proposed "top-up" fees to explain why they are misguided.

Alan Smithers, Sydney Jones professor of education and director of the Centre for Education and Employment Research at Liverpool University, writes that the government must be tough on truancy, but also on the causes of truancy.

THE GUARDIAN

Europe will continue to allow the patenting of genes from living things until next year at least, after regulators at a key conference ducked the issue.

MISCELLANY

Scientists at the United States National Institute of Health in Maryland have developed a DNA vaccine for the deadly Ebola virus in monkeys, paving the way for a preventative drug for humans. ( Guardian, Independent, Daily Telegraph )

Researchers at Inserm, a French medical institute in Paris, who transplanted stem cells from foetuses into the brains of Huntington's Chorea sufferers, said cognitive function and control of movements improved. ( Independent, Daily Telegraph )

Scientists have worked out the perfect amount of gravy to bring out the best in a Sunday roast dinner. ( Guardian, Daily Mail, Times, Daily Telegraph )   

You've reached your article limit.

Register to continue

Registration is free and only takes a moment. Once registered you can read a total of 3 articles each month, plus:

  • Sign up for the editor's highlights
  • Receive World University Rankings news first
  • Get job alerts, shortlist jobs and save job searches
  • Participate in reader discussions and post comments
Register

Have your say

Log in or register to post comments